Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of

Kuruppu Arachchillage Praboda Priyangi Kuruppuarachchi1,2, Yunyueng Jang1,2, Sang Heui Seo1,2

  • 1Laboratory of Influenza Research, College of Veterinary Medicine, Chungnam National University, 34134 Daejeon, Republic of Korea.

Abstract

Insights

The wild-type SARS-CoV-2 variant showed the highest pathogenicity, followed by Delta, then Omicron. This comparative study analyzed immune gene expression in K18-hACE2 mice to understand variant virulence.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Emerging SARS-CoV-2 variants pose significant public health risks.
  • Understanding variant pathogenicity is crucial for developing effective therapeutics.
  • This study investigates immune gene expression differences across SARS-CoV-2 variants.

Purpose of the Study:

  • To compare the pathogenicity of wild-type, Delta, and Omicron SARS-CoV-2 variants.
  • To analyze immune response gene expression patterns in K18-hACE2 mice infected with different SARS-CoV-2 variants.
  • To identify key immune markers associated with variant-specific pathogenicity.

Main Methods:

  • K18-hACE2 mice were infected with wild-type, Delta, or Omicron SARS-CoV-2 variants.
  • Lung, brain, and kidney tissues were collected on day 6 post-infection.
  • RT-qPCR was used to compare mRNA expression of 39 immune genes; viral titers were measured via TCID50 assay.

Main Results:

  • Toll-like receptor (TLR) expression was upregulated in wild-type and Delta groups, but not Omicron.
  • Wild-type infection led to the highest expression of cytokines (e.g., IL-1α, IL-1β) and chemokines (e.g., CCL4, CXCL9) in lungs.
  • Omicron infection primarily upregulated apoptotic factors in brain tissue, unlike wild-type and Delta variants.

Conclusions:

  • Wild-type SARS-CoV-2 exhibited the highest pathogenicity.
  • The Delta variant demonstrated intermediate pathogenicity.
  • The Omicron variant displayed the lowest pathogenicity among the tested variants.